You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 851 to 875 of about 5897
Next 25
07/29/2020
An Emerging Medical Market Play with Great Opportunity
07/28/2020
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Dianhydrogalactitol (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells
07/24/2020
FDA Grants Rare Pediatric Disease Designation to ONC201 for the Treatment of H3 K27M-Mutant Glioma
Trump administration unveils four executive orders aimed at lowering drug prices
07/22/2020
GBM awareness day: Contact your legislators!
First Recurrent GBM Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
07/11/2020
Comparative Epidemiology of Gliosarcoma and Glioblastoma and the Impact of Race on Overall Survival: A Systematic Literature Review
07/09/2020
Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors
07/08/2020
Musella Foundation awards another brain tumor research grants!
07/07/2020
Survival, Costs, and Health Care Resource Use by Line of Therapy in US Medicare Patients With Newly Diagnosed Glioblastoma: A Retrospective Observational Study
07/03/2020
Everolimus improves the efficacy of dasatinib in PDGFRa-driven glioma
Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients
Is polio the answer to curing brain tumors?
07/01/2020
Early Imaging Marker of Progressing Glioblastoma: A Window of Opportunity
06/30/2020
Musella Foundation awards two more brain tumor research grants!
06/29/2020
First annual Dragon Derby!
We need your supprt for the Promising Pathway Act
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study
06/28/2020
David Zagzag, MD, Ph.D. Recognized as a Professional of the Year for 2020 by Strathmore`s Who`s Who Worldwide
06/27/2020
ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
06/25/2020
A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas
06/24/2020
Musella Foundation Copay Program now closed to new patients
New class of precision medicine strips cancer of its DNA defenses
DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II